• Users Online: 144
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 3  |  Issue : 3  |  Page : 88-93

Mesenchymal stem cell and hematopoietic stem cell transplantation for vasculitis


Center of Laboratory Medicine, Union Hospital of Fujian Medical University, Fuzhou, Fujian 350001, China

Correspondence Address:
Dr. Lianming Liao
Center of Laboratory Medicine, Union Hospital of Fujian Medical University, Fuzhou, No. 29, Xinquan Road, Fuzhou, Fujian 350001
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/VIT.VIT_20_20

Rights and Permissions

Vasculitis is a great therapeutic challenge. Currently, no effective treatments are available. Although biologics are emerging as new therapeutic alternatives, steroids remain the mainstay of the treatment. Similar to other immune-mediated diseases, refractory vasculitis seems to be a potential target of both bone marrow and mesenchymal stem cell transplantation. Preliminary data show stem cell-based therapies are effective for several types of vasculitis that are steroid-refractory. However, clinical data are sparse due to the limited number of patients. More studies are needed to confirm the preliminary results. In addition, optimization of the therapeutical regimens of stem cell transplantation is necessary in future.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed236    
    Printed19    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal